A new study has shown that screening for prostate cancer could reduce deaths from the disease by about a fifth.
According to the long-term results of a major European study, screening appeared to reduce prostate cancer deaths by 15 percent at 9 years, and this improved to 22 percent at 11 years, and the risk of advanced prostate cancer was also smaller in the screening group.
.
